Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up – MarketWatch
Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to…
Is IV Vitamin Therapy Worth the Hype? You Might Want to Follow Your Gut.
In a world fixated with quick fixes, one wellness trend takes “getting to the point” quite literally. Intravenous,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
ADHD Pills Beget Other Drugs, New Hormone Therapy Guidelines and Obesity Drug Price Cuts | WSJ Health for November 21
This is an edition of the WSJ Health newsletter, a weekly briefing on what’s new in health, medicine,…
GE HealthCare to Acquire Intelerad for $2.3 Billion
GE HealthCare GEHC 3.37%increase; green up pointing triangle Technologies will buy medical imaging software provider Intelerad for $2.3…
What Comes After the FDA’s Drug Monopoly?
The FDA’s monopoly over drug and device approval—created by the 1938 Food, Drug, and Cosmetic Act and expanded…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…